The antimalarial hydroxychloroquine (HCQ) has demonstrated several crucial properties for
the treatment of systemic lupus erythematosus (SLE). Herein, we reviewed the main HCQ …

The anti-malarial drugs chloroquine (CQ) and primarily the less toxic hydroxychloroquine
(HCQ) are currently used to treat autoimmune diseases for their immunomodulatory and anti …

Background: Antimalarial drugs (AMs), chloroquine (CQ) and hydroxychloroquine (HCQ),
are frequently withdrawn in patients with lupus with either severe or remitting disease …

The antiphospholipid syndrome (APS) is an autoimmune disease characterized by the
occurrence of venous and/or arterial thrombosis and pregnancy morbidity in the presence of …

Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease that affects
various organs. Lupus nephritis is one of the most common, and most important, serious …

Antimalarials have shown beneficial effects on systemic lupus erythematosus (SLE) activity.
Our aim was to investigate whether antimalarials protect against thrombosis and influence …

Neuropsychiatric (NP) involvement in Systemic Lupus Erythematosus (SLE), can be a
severe and troubling manifestation of the disease that heavily impacts patient's health …

Objective To examine whether hydroxychloroquine (HCQ) usage is associated with a
reduced risk of damage accrual in patients with systemic lupus erythematosus (SLE) …

Objectives We wanted to estimate the magnitude of the risk from all-cause, cause-specific
and sex-specific mortality in patients with SLE and relative risks compared with matched …

The efficacy of antimalarials, especially hydroxychloroquine (HCQ), in preventing systemic
lupus erythematosus (SLE) flares is well demonstrated. However, many studies show that …